Skip to main content
Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Agonistic autoantibodies against ß2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients

  • Bettina Hohberger ,

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Project administration, Supervision, Visualization, Writing – original draft

    Affiliation Department of Ophthalmology, University of Erlangen-Nürnberg, Friedrich-Alexander-University of Erlangen-Nürnberg, Erlangen, Germany

  • Sami Hosari,

    Roles Methodology, Software, Writing – review & editing

    Affiliation Department of Ophthalmology, University of Erlangen-Nürnberg, Friedrich-Alexander-University of Erlangen-Nürnberg, Erlangen, Germany

  • Gerd Wallukat,

    Roles Methodology, Writing – review & editing

    Affiliation Max Delbrück Center for Molecular Medicine, Berlin, Germany

  • Rudolf Kunze,

    Roles Supervision, Writing – review & editing

    Affiliation Science Office, Berlin-Buch, Campus Max Delbrück Center for Molecular Medicine, Berlin, Germany

  • Johann Krebs,

    Roles Investigation

    Affiliation Department of Ophthalmology, University of Erlangen-Nürnberg, Friedrich-Alexander-University of Erlangen-Nürnberg, Erlangen, Germany

  • Meike Müller,

    Roles Investigation

    Affiliation Department of Ophthalmology, University of Erlangen-Nürnberg, Friedrich-Alexander-University of Erlangen-Nürnberg, Erlangen, Germany

  • Till Hennig,

    Roles Formal analysis

    Affiliation Department of Ophthalmology, University of Erlangen-Nürnberg, Friedrich-Alexander-University of Erlangen-Nürnberg, Erlangen, Germany

  • Robert Lämmer,

    Roles Investigation

    Affiliation Department of Ophthalmology, University of Erlangen-Nürnberg, Friedrich-Alexander-University of Erlangen-Nürnberg, Erlangen, Germany

  • Folkert Horn,

    Roles Data curation, Formal analysis, Writing – review & editing

    Affiliation Department of Ophthalmology, University of Erlangen-Nürnberg, Friedrich-Alexander-University of Erlangen-Nürnberg, Erlangen, Germany

  • Luis E. Muñoz,

    Roles Data curation, Formal analysis

    Affiliation Department of Internal Medicine 3—Rheumatology and Immunology, University of Erlangen-Nürnberg, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Germany

  • Martin Herrmann ,

    Contributed equally to this work with: Martin Herrmann, Christian Mardin

    Roles Conceptualization, Data curation, Supervision, Visualization, Writing – review & editing

    Affiliation Department of Internal Medicine 3—Rheumatology and Immunology, University of Erlangen-Nürnberg, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Germany

  • Christian Mardin

    Contributed equally to this work with: Martin Herrmann, Christian Mardin

    Roles Conceptualization, Methodology, Software, Supervision, Writing – review & editing

    Affiliation Department of Ophthalmology, University of Erlangen-Nürnberg, Friedrich-Alexander-University of Erlangen-Nürnberg, Erlangen, Germany



Agonistic β2-adrenergic receptor autoantibodies (β2-agAAb) have been observed in sera of patients with ocular hypertension and open-angle glaucoma (OAG). They target the β2-receptors on trabecular meshwork, ciliary body and pericytes (Junemann et al. 2018; Hohberger et al. 2019). In addition to their influence on the intraocular pressure, an association to retinal microcirculation is discussed. This study aimed to investigate foveal avascular zone (FAZ) characteristics by en face OCT angiography (OCT-A) in glaucoma suspects and its relationship to β2-agAAb status in patients with OAG.

Material and methods

Thirty-four patients (28 OAG, 6 glaucoma suspects) underwent standardized, clinical examination including sensory testing as white-on-white perimetry (Octopus G1, mean defect, MD) and structural measures as retinal nerve fibre layer (RNFL) thickness, neuroretinal rim width (BMO-MRW), retinal ganglion cell layer (RGCL) thickness, and inner nuclear layer (INL) thickness with high-resolution OCT. FAZ characteristics were measured by OCT-A scans of superficial vascular plexus (SVP), intermediate capillary plexus (ICP), and deep capillary plexus (DCP). FAZ-R was calculated (area FAZ (SVP)/area FAZ (ICP)). Using cardiomyocyte bioassays we analysed serum samples for the presence of β2-agAAb.


(I) Total mean FAZ area [mm2]: 0.34±0.16 (SVP), 0.24±0.12 (ICP), and 0.49±0.24 (DCP); mean FAZ-R 1.58±0.94. No correlation was seen for FAZ-R with MD, RNFL, BMO-MRW, RGCL thickness and INL thickness (p>0.05). (II) ß2-agAAb have been observed in 91% patients and showed no correlation with MD, RNFL, BMO-MRW, RGCL thickness and INL thickness (p>0.05). (III) FAZ-R correlated significantly with the β2-agAAb-induced increase of the beat rate of cardiomyocyte (p = 0.028).


FAZ characteristics did not correlate with any glaucoma associated functional and morphometric follow-up parameter in the present cohort. However, level of β2-agAAb showed a significantly correlation with FAZ-ratio. We conclude that β2-agAAb might be a novel biomarker in glaucoma pathogenesis showing association to FAZ-ratio with OCT-A.


Glaucoma is known as a multifactorial neurodegenerative disease. The exact pathomechanism is still elusive. Thus, several factors seem to act and interact within this neurodegenerative disorder. Next to an increased intraocular pressure (IOP), being the main risk factor, e.g. oxidative stress [1], trace elements [2], an altered trabecular meshwork [3], immunological [4] and neuroinflammatory processes [5] are involved. In addition vascular dysregulation was seen as pathogenetic agent [6]. It is supposed that due to an insufficient nutritive support of retinal ganglion cells via altered microcirculation neurodegeneration could be promoted. A restricted autoregulation with additional vasospasms may enhance this pathophysiologic changes [7].

OCT-angiography (OCT-A) offers the diagnostic option to visualize and quantify retinal microcirculation with subsequent software tools (e.g. Erlangen Angio Tool [8]). Heidelberg Spectralis II OCT-A (Heidelberg, Germany) is able to scan macular microcirculation in three layers: superficial vascular plexus (SVP, thickness: 80 μm), intermediate capillary plexus (ICP, thickness: 50μm), and deep capillary plexus (DCP, thickness: 40 μm). These layers correspond well with anatomical structures [9]: SVP corresponds mainly to the ganglion cell layer (GCL), ICP to the inner plexiform layer (IPL) and inner nuclear layer (INL), and DCP mainly to the outer plexiform layer (OPL, Fig 1).

Fig 1. Structure OCT detail of the macula with the corresponding structural OCT layers and OCT-A slabs of the inner retina (yellow box).

Image courtesy by Heidelberg Engineering, Heidelberg, Germany.

Glaucoma damage focuses on GCL loss, thus, we hypothesize that changes in retinal microcirculation might be accented in SVP and adjacent ICP, potentially most obvious in foveal avascular zone characteristics (FAZ) [10]. A potential link between microvascular retinal alterations and immunological findings in glaucoma might be mirrored by specific agonistic autoantibodies against the ß2-adrenoceptors (ß2-agAAb), as ß2-adrenoreceptors (ß2-AR) are present on pericytes of retinal microvessels [11]. We observed these ß2-agAAb in a high percentage in sera of patients with primary (POAG), secondary open-angle glaucoma (SOAG) or ocular hypertension (OHT), yet not in controls [12, 13]. The target of ß2-agAAb is additionally present on cells of the trabecular meshwork (TM) and ciliary body [14, 15], both involved in regulation of IOP. Thus, it is assumed that ß2-agAAb might be involved in the pathological increase of IOP via rise of outflow resistance in the TM and increase of production of aqueous humor in the ciliary body. The hypothesis of an increase of outflow resistance is supported by data of Putney et al., describing an increased volume of trabecular meshwork cells in patients with glaucoma. The altered cell volume was reportedly induced by osmotic changes due to Na+-K+-Clcotransporters, activated by ß-adrenergic stimulation [16]. Clinical data of a proof-of-principle study supported the hypothesis of a potential involvement of ß2-agAAb in glaucoma pathogenesis, as IOP showed a transient decrease after immunadsorption of all immunoglobulins including ß2-agAAb [12].

The aim of the present study was to investigate foveal avascular zone (FAZ) characteristics of SVP, ICP, and DCP by en face OCT-A in glaucoma suspects and open-angle glaucoma patients (OAG) in relation to their corresponding β2-agAAb status.

Materials and methods


Thirty-four patients were recruited from the Department of Ophthalmology and Eye Hospital, Friedrich-Alexander-University Erlangen-Nürnberg (Erlangen Glaucoma Registry, ISSN 2191-5008, CS-2011; NTC00494923 [17]): 6 glaucoma suspects (4 ocular hypertension, OHT; 2 pre-perimetric OAG), 28 patients with OAG. Demographic data for group and subgroups are displayed in Table 1.

Table 1. Demographic data for total cohort and subdivided into glaucoma suspects and glaucoma patients: Age, gender, intraocular pressure at the day of examination with glaucoma therapy (IOP), number of antiglaucomatous eye drops, best corrected visual acuity (BCVA): Mean±SD; number family history of glaucoma, diabetes, hypertension.

All patients underwent a standardized ophthalmological examination, which included slit-lamp biomicroscopy, funduscopy and Goldmann applanation tonometry. Additionally, white-on-white perimetry (Octopus 500, program G1, Interzeag, Schlieren, Switzerland; mean defect (MD), n = 34) and measurements of the global retinal nerve fiber layer (RNFL, n = 33), Bruchs’ membrane opening—minimum rim width (BMO-MRW, n = 33), retinal ganglion cell layer (RGCL, n = 33) and inner nuclear layer (INL, n = 33) were done (Heidelberg OCT II Spectralis, version, Heidelberg Engineering, Heidelberg, Germany). Diagnosis of glaucoma suspects and POAG were based according to the criteria of the Erlangen Glaucoma registry [17]. Glaucomatous optic disc was classified after Jonas [18]. If both eyes met the inclusion criteria, data of one eye were chosen randomly for statistical analysis. Every participant provided informed written consent. The study protocol was performed in accordance with the tenets of the Declaration of Helsinki and was approved by the local ethics committee of the university of Erlangen-Nürnberg.

Glaucoma suspects

Diagnosis of glaucoma suspects was based on a repeated (≥2 times) increased IOP > 21 mmHg. Visual fields showed no glaucomatous scotoma. The optic disc was with (diagnosis: pre-perimetric OAG, classified as proposed by Jonas, [18]) or without glaucomatous alterations (diagnosis: OHT).


The diagnosis of POAG was based on an open anterior chamber angle. IOP had to be increased (> 21 mmHg), repeated ≥2 times. The optic disc showed glaucomatous alterations according to the classification after Jonas [18]. Visual field yielded glaucomatous scotoma (confirmed at least once): ≥3 adjacent test points having a deviation ≥ 5 dB and with one test point with a deviation > 10 dB lower than normal or ≥2 adjacent test points with a deviation ≥ 10 dB or at least 3 adjacent test points with a deviation ≥ 5 dB abutting the nasal horizontal meridian or a mean visual field defect of > 2.6 dB.

Cardiomyocyte bioassay

For the functional experiments we used neonatal rat cardiomyocytes in primary culture. The cells were prepared freshly every week with the permission 49004/19 of the Max Delbrück Centre for Molecular Medicine. Cell culture of cardiac myocytes derived from heart ventricle of 1–2 day-old Sprague-Dawley rats [19]. We included this information into the revised version of the manuscript. After digestion with a 0.25% solution of crude porcine trypsin (Serva, Germany), the cells were dispersed and suspended in a SM20-I medium (Biochrom, Germany), glutamine (Serva, Germany), containing penicillin (Heyl, Germany), streptomycin (HEFA Pharma; Germany), 10% heat-inactivated neonatal calf serum (Gibco, Germany), hydrocortisone (Merck, Germany), and fluorodeoxyuridine (Serva, Germany). The cardiomyocyte cells were seeded with a field density of 160.000 cells/cm2. The culture medium was refaced after 24 hours. Previous to stimulation the cells were cultured for 3–4 days at 37°C. The medium was renewed with fresh culture solution 2 hours before start of the experiments. Beating rate was counted of 7–10 selected spontaneously beating cardiomyocte or synchronously contracting cell clusters per flask for 15 seconds, which were placed on a heated stage of an inverted microscope at 37°C (cut-off < 2.0 Units, U). The cardiomyocytes were incubated with the immunoglobulin fractions of each probands’ sera (duration: 60 min; dilution of 1:40). The change in beating rate after incubation with each probands’s sera was measured, respectively. 1 Unit (U) reflects 4 beats/min. Cutoff was 2 U.


We performed en face OCT-A measurements employing a Heidelberg OCT II Spectralis device (Heidelberg, Germany). The OCT-A scan recorded a retinal slab of 2.9 mm x 2.9 mm with a 15° angle and a lateral resolution of 5.7 μm/pixel. Data were exported and analyzed by the Erlangen Angio-Tool (EA-Tool, Matlab; The MathWorks, Inc., R2017b) [20]. EA-Tool used binariziation by using the Otsu thresholding algorithm [21] and Frangi vesselness filter [22]. En face OCT-A application in combination with EA-Tool allowed analysis of FAZ area in three different layers: superficial vascular plexus (SVP), intermediate capillary plexus (ICP), and deep capillary plexus (DCP). We present FAZ data for SVP, ICP and DCP, respectively.

Statistical analysis

Statistical analysis was done using SPSS (version 21.0) and Excel (version 2010). The FAZ-to-FAZ-ratio (FAZ-R) between FAZ of SVP and ICP was calculated. Data were presented by mean ± standard deviation and percentage. T-test and correlation analysis were performed.



Functional and morphometric data of Spectralis OCT II measurements are displayed in Fig 2.

Fig 2. Perimetric and morphometric data of total, glaucoma suspects and patients with open-angle glaucoma (OAG): Mean defect (MD), retinal nerve fiber (RNF), Bruchs’ membrane opening—minimum rim width (BMO-MRW), retinal ganglion cell (RGC), inner nuclear layer (INL).

OCT-A data of all patients showed a mean FAZ of 0.34±0.16 mm2 (range: 0.13 mm2–0.92 mm2) in SVP, 0.24±0.12 mm2 (range: 0.08 mm2–0.59 mm2) in ICP, and 0.49±0.24 mm2 (range: 0.18 mm2–1.09 mm2) in DCP. FAZ-R yielded a mean of 1.58±0.94.

Subgroup analysis showed a mean FAZ of 0.21±0.04 mm2 (range: 0.13 mm2–0.26 mm2) in SVP, 0.12±0.05 mm2 (range: 0.08 mm2–0.21 mm2) in ICP, and 0.29±0.06 mm2 (range: 0.22 mm2–0.37 mm2) in DCP in glaucoma suspects. FAZ-R of glaucoma suspects yielded a mean of 1.81±0.63. Patients with OAG showed a mean FAZ of 0.36±0.17 mm2 (range: 0.17 mm2–0.92 mm2) in SVP, 0.26±0.12 mm2 (range: 0.12 mm2–0.59 mm2) in ICP, and 0.53±0.24 mm2 (range: 0.18 mm2–1.09 mm2) in DCP. Additionally, FAZ-R yielded a mean of 1.53±0.99.

No significant correlation was seen for FAZ-R with MD (p>0.05), RNF thickness (p>0.05), BMO-MRW (p>0.05), RGC thickness (p>0.05), and INL thickness (p>0.05) for group (total cohort) and subgroup analysis (glaucoma suspects, OAG), respectively.

β2-agAAb seropositivity

A β2-agAAb seropositivity was observed in 91% of all patients with a mean increase of beat in comparison to the basal beating rate of 4.5±1 U (range: 2.3–7.5 U, Fig 3). Only 9% of all patients turned out to be seronegative for β2-agAAb (<2.0 U).

Fig 3. Anti-adrenergic activity β2-agAAb [U] subdivided in glaucoma suspects and glaucoma patients (raw data; median).

Primary functional and morphometric data considering β2-agAAb seropositivity are presented in Table 2.

Table 2. Perimetric and morphometric data considering β2-agAAb seropositivity: Mean defect (MD), retinal nerve fiber (RNFL), Bruchs’ membrane opening—minimum rim width (BMO-MRW), retinal ganglion cell (RGCL), inner nuclear layer (INL).

β2-agAAb seropositive patients showed no correlation of β2-agAAb beat rate with MD (p>0.05), RNF thickness (p>0.05), BMO-MRW (p>0.05), RGC thickness (p>0.05) and INL thickness (p>0.05) for group (total cohort) and subgroup (glaucoma suspects, OAG) analysis, respectively (Fig 4).

Fig 4. Correlation plots of anti-adrenergic activity β2-agAAb [U] and glaucoma follow-up parameters (mean defect, MD; Bruchs’ membrane opening—minimum rim width, BMO-MRW; inner nuclear layer, INL; retinal nerve fiber, RNF; retinal ganglion cell, RGC): We observed no significant correlations for all presented parameters (p>0.05, Pearson’s correlation).

Considering β2-agAAb seropositivity a mean FAZ of 0.34±0.17 mm2 (range: 0.13 mm2–0.92 mm2) was observed in β2-agAAb seropositive and 0.32±0.20 mm2 (range: 0.20 mm2–0.55 mm2) in β2-agAAb seronegative patients for the SVP layer. Data of ICP showed a mean FAZ of 0.24±0.13 mm2 (range: 0.08 mm2–0.59 mm2) in β2-agAAb seropositive and 0.27±0.09 mm2 (range: 0.21 mm2–0.37 mm2) in β2-agAAb negative patients. FAZ of DCP was 0.48±0.22 mm2 (range: 0.18 mm2–1.09 mm2) in β2-agAAb seropositive and 0.56±0.42 mm2 (range: 0.25 mm2–1.03 mm2) in β2-agAAb negative patients. We observed a mean FAZ-R of 1.62±0.97 in β2-agAAb seropositive and 1.13±0.31 in β2-agAAb negative patients.

A significant correlation of β2-agAAb beat rate with FAZ-R was observed (p = 0.028, Fig 5).

Fig 5. Anti-adrenergic activity β2-agAAb [U] considering FAZ-ratio (cutoff 1.4; p = 0.028), plotted as raw data and median.


Agonistic autoantibodies can be found in several diseases with a common vascular component [19, 2326]. β2-agAAb, able to activate the adrenergic ß2-AR have recently been reported in patients with POAG, SOAG and even OHT, yet not in persons with healthy eyes [12, 13] Thus, we assume that β2-agAAb is involved in the etiology glaucoma by a common mechanism. A previous study offered an involvement of these β2-agAAb in the regulation of IOP [12]. ß2-AR expressed on pericytes, on the cells of the ciliary body and the trabecular meshwork [14, 15] represent potential molecular targets that cause the clinical findings. Thus, the present study aimed to investigate a potential involvement of β2-agAAb on retinal microcirculation in patients with glaucoma. Ninety-one percent of all patients were seropositive for ß2-agAAb, not correlating with standard glaucoma follow-up parameters (MD, RNFL, BMO-MRW, RGCL-, INL thickness). Analysis of FAZ in the three different macula layers yielded that FAZ-R correlated significantly with β2-agAAb beat rate in β2-agAAb seropositive patients, yet not with MD, RNF thickness, BMO-MRW, RGC thickness, and INL thickness.

OCT angiography is a novel diagnostic tool to visualize the retinal microcirculation of the macula and the peripapillary region. Invasive techniques (e.g. fluorescence angiography) required the application of dyes with potential side effects. As non-invasive method OCT-A does not include dyes and thus offers a basis for subsequent research issues. A motion contrast algorithm with high spatial resolution yields an improvement of the three-dimensional image of the retinochoroidal vasculature. In the beginning retinal microvasculature could be resolved into 2 different layers (superficial vascular plexus (SVP) and deep capillary plexus (DCP)) [27] with current improvements up to 3 layers in the latest OCT-A tools (SVP, ICP, DCP) [28]. Experimental studies showed a good correlation of these layers with anatomical findings [9]. Spectralis II OCT-A uses a probabilistic full-spectrum amplitude decorrelation algorithm (FSADA), reducing the signal-to-noise ratio with improvement of axial resolution (3.9 μm/pixel) [29]. Additional implementation of projection artefact removal (PAR) tool allows analysis of deeper retinal microvasculature without overlying artefacts. As no commercial software was available for analysis of OCT-A images, a custom made Erlangen-Angio-Tool (EA-Tool) was coded. EA-tool uses a Frangi’s vesselness filter for convolving [30] and an Otsu’s thresholding algorithm for binarization of the image raw data [21]. As previous data showed an even good reliability for the EA-Tool [20] this was the basis for its use in clinical and research settings.

Clinical studies identified an altered retinal microcirculation in a wide range of retinochoroidal diseases (e.g. diabetic retinopathy, vasculitis, age-related maculopathy) [3135]. Even glaucoma patients’ microcirculation was seen to be impaired in OCT-A imaging (see review [36, 37]). Significantly different vessel densities were observed in glaucoma patients when compared to healthy controls with good areas under the receiver operating characteristic curve (AUC) [38, 39]. Interestingly, in early glaucoma diagnosis OCT-A data were hypothesized to be better diagnostic tools than retinal nerve fiber layer thickness [40]. The present study showed that especially the differences between the three retinochoroidal layers might be of interest in early glaucoma diagnosis. The ratio of SVP to ICP confirmed this as this FAZ-R did not correlate with canonical glaucoma follow-up parameters (MD, RNF thickness, BMO-MRW, RGC thickness, and INL thickness). However, it correlated with the levels of β2-agAAb. We detected these autoantibodies in patients with early glaucoma disease or OAG [12]. Thus, we propose that parameters (β2-agAAb, FAZ-R), which are present in very early stages of glaucoma pathogenesis might offer a novel, early option for an extended glaucoma diagnosis. As they correlate by each other, yet not with standard glaucoma parameters, it might be that β2-agAAb and FAZ-R recruit a further molecular pathway, which does not influence the canonical glaucoma follow-up parameters. As we observed a correlation of FAZ ratio with the β2-agAAb beat rate in the present study and a seropositivity of β2-agAAb even in eyes with normal RFNL and normal RGCL (i.e. ocular hypertension) in a previous study [12], we hypothesize that β2-agAAb are present very early in glaucoma pathogenesis and are linked to microcirculation.

β2-agAAb are frequent. Patients with POAG and SOAG showed β2-agAAb in >78% of the patients [13, 41] β2-agAAb “hyperactivate” the adrenergic β2-AR in various tissues (e.g. ciliary body, and trabecular meshwork) with consecutive influence on IOP via hypersecretion of aqueous humor and decrease of the outflow facility [12]. Activation of β2-and β3-AR on retinal blood vessels reportedly induce vasodilatation [42, 43]. A ‘direct’ autonomic innervation is not present in retinal blood vessels [44]. Yet, sympathetic activation can activate β2-AR ‘indirectly’ via its transmitter adrenaline [42]. Additionally, β2- and β3-AR agonists reportedly mediate retinal vasodilatation [45]. Considering the present data available in literature, β2-AR mediated vasodilation is an important factor, regulating the retinal microcirculation. To the best of our knowledge, the exact molecular pathway mediated by β2-AR in retinal vessels is still elusive. It was reported that in ischemia the behavior of β2-AR varied: whereas a subgroup was internalized, a second group showed an alternate desensitization that finally caused an increase in affinity [46]. This in vitro observation supports our hypothesis of a link between β2-agAAb (via β2-AR) and impaired retinal microcirculation in glaucoma eyes. As FAZ-R significantly correlated with β2-agAAb beat rate (p = 0.028), the present data show that the size of different retinal microvascular layers was mutually altered in the presence of β2-agAAb and resulted in similar FAZ sizes of both microvascular layers (Fig 6).

Fig 6.

FAZ of superficial vascular plexus (SVP; green; a, d), intermediate capillary plexus (ICP; yellow; b, e), and deep capillary plexus (DCP; pink; c, f) in a β2-agAAb seronegative (a-c) and seropositive (d-f) OAG patient including a schematic sketch of the FAZ of SVP, ICP, DCP considering β2-agAAb seropositivity.

If the ‘lacking’ vessels are really missing or even not perfused remains unknown. The present study suggests that β2-agAAb influence the retinal microcirculation. We hypothesize that the influence β2-agAAb on FAZ-R is mediated by the prolonged activation of the β2-receptor. Contrary to canonical agonists, activating the β2-receptor only for a short-term, agAAb are known to mediate a stable and even prolonged signal. This uncontrolled hyperactivation of the G-protein coupled receptor can result in cell-toxic effects, as observed for agAAb against ß1AR (cardiotoxic effect) in a rat model [24]. Differences or ratios between FAZ of the distinct microvascular layers detected in OCT-A are sensible markers for early pathogenetic alterations. Retinal microcirculation should be considered a single nutritional unit. Thus, pathological alterations in one of the layers of the microvascular most likely influence the other ones.

The present study is not without limitations. Study size is small (n = 34), yet data should be seen as having a pilot character and should be confirmed in subsequent studies. Considering the number of subjects per group (β2-agAAb positive vs. negative), we did not make a group comparison. Yet, statistically significant correlations between FAZ-R and β2-agAAb were already observed in this small patient group. Furthermore, the study focused on changes of FAZ in glaucoma suspects and patients with OAG taking into account the status of β2-agAAb. Subsequent research will investigate potential alterations in vessel density of SVP, ICP and DCP in the presence of β2-agAAb.


FAZ characteristics of the macula showed a significantly correlation with β2-agAAb beat rate in glaucoma suspects and patients with open-angle glaucoma. These data support the hypothesis of a pathological role of β2-agAAb in the microcirculation of the macula. Level of β2-agAAb did not correlate with the canonical glaucoma follow-up parameters. Yet, with FAZ characteristics, β2-agAAb should be considered a novel risk factor of glaucoma. In addition, FAZ-R should be seen as a novel early diagnostic morphological marker of glaucoma disease.


  1. 1. Jacob MM, Pai HV, Gnanaharan J, Kamath S. Serum Bile Acids in Patients with Primary Open Angle Glaucoma. Journal of glaucoma. 2018. pmid:29847360
  2. 2. Hohberger B, Chaudhri MA, Michalke B, Lucio M, Nowomiejska K, Schlotzer-Schrehardt U, et al. Levels of aqueous humor trace elements in patients with open-angle glaucoma. J Trace Elem Med Biol. 2018;45:150–5. pmid:29173472
  3. 3. Tektas OY, Lutjen-Drecoll E. Structural changes of the trabecular meshwork in different kinds of glaucoma. Experimental eye research. 2009;88(4):769–75. pmid:19114037
  4. 4. Joachim SC, Reinehr S, Kuehn S, Laspas P, Gramlich OW, Kuehn M, et al. Immune response against ocular tissues after immunization with optic nerve antigens in a model of autoimmune glaucoma. Molecular vision. 2013;19:1804–14. pmid:23946635
  5. 5. Wei X, Cho KS, Thee EF, Jager MJ, Chen DF. Neuroimmflammation and microglia in glaucoma: time for a paradigm shift. Journal of neuroscience research. 2018.
  6. 6. Flammer J. The vascular concept of glaucoma. Survey of ophthalmology. 1994;38 Suppl:S3–6. pmid:7940146
  7. 7. Grieshaber MC, Mozaffarieh M, Flammer J. What is the link between vascular dysregulation and glaucoma? Survey of ophthalmology. 2007;52 Suppl 2:S144–54. pmid:17998040
  8. 8. Hosari S, Hohberger B, Theelke L, Sari H, Lucio M, Mardin CY. OCT Angiography: Measurement of Retinal Macular Microvasculature with Spectralis II OCT Angiography—Reliability and Reproducibility. Ophthalmologica Journal international d’ophtalmologie International journal of ophthalmology Zeitschrift fur Augenheilkunde. 2020;243(1):75–84. pmid:31509842
  9. 9. Campbell J, Zhang M, Hwang T, Bailey S, Wilson D, Jia Y, et al. Detailed vascular anatomy of the human retina by projection-resolved optical coherence tomography angiography. Sci Rep-Uk. 2017;7:42201. pmid:28186181
  10. 10. Choi J, Kwon J, Shin JW, Lee J, Lee S, Kook MS. Quantitative optical coherence tomography angiography of macular vascular structure and foveal avascular zone in glaucoma. PloS one. 2017;12(9):e0184948. pmid:28934255
  11. 11. Ferrari-Dileo G. Beta 1 and beta 2 adrenergic binding sites in bovine retina and retinal blood vessels. Investigative ophthalmology & visual science. 1988;29(5):695–9. pmid:2835327
  12. 12. Junemann A, Hohberger B, Rech J, Sheriff A, Fu Q, Schlotzer-Schrehardt U, et al. Agonistic Autoantibodies to the beta2-Adrenergic Receptor Involved in the Pathogenesis of Open-Angle Glaucoma. Frontiers in immunology. 2018;9:145. pmid:29483909
  13. 13. Hohberger B MC, Hosari S, Lämmer R, Kunze R, Schlötzer-Schrehardt U, et al. Are agonistic β2-adrenergic receptor autoantibodies present in normal tension glaucoma and secondary open-angle glaucoma?. ARVO; Vancouver: IOVS; 2019.
  14. 14. Crider JY, Sharif NA. Adenylyl cyclase activity mediated by beta-adrenoceptors in immortalized human trabecular meshwork and non-pigmented ciliary epithelial cells. Journal of ocular pharmacology and therapeutics: the official journal of the Association for Ocular Pharmacology and Therapeutics. 2002;18(3):221–30. pmid:12099543
  15. 15. Wax MB, Molinoff PB. Distribution and properties of beta-adrenergic receptors in human iris-ciliary body. Investigative ophthalmology & visual science. 1987;28(3):420–30. pmid:3030954
  16. 16. Putney LK, Vibat CR, O’Donnell ME. Intracellular Cl regulates Na-K-Cl cotransport activity in human trabecular meshwork cells. The American journal of physiology. 1999;277(3 Pt 1):C373–83. pmid:10484324
  17. 17. Hohberger B, Monczak E, Mardin CY. [26 Years of the Erlangen Glaucoma Registry: Demographic and Perimetric Characteristics of Patients Through the Ages]. Klinische Monatsblatter fur Augenheilkunde. 2019;236(5):691–8. pmid:28750434
  18. 18. Jonas JB, Gusek GC, Naumann GO. Optic disc morphometry in chronic primary open-angle glaucoma. I. Morphometric intrapapillary characteristics. Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 1988;226(6):522–30. pmid:3209079
  19. 19. Wallukat G, Wollenberger A. Effects of the serum gamma globulin fraction of patients with allergic asthma and dilated cardiomyopathy on chronotropic beta adrenoceptor function in cultured neonatal rat heart myocytes. Biomedica biochimica acta. 1987;46(8–9):S634–9. pmid:2449194
  20. 20. Hosari S HB, Theelke L, Hasan S, Mardin CY. OCT angiography: Measurement of retinal macular microvasculature with Spectralis II OCT angiography reliability and reproducibility ARVO Imaging Conference; Vancouver: IOVS; 2019.
  21. 21. Otsu N. A threshold selection method from gray-level histograms. IEEE transactions on systems, man, and cybernetics. 1979;9(1):62–6.
  22. 22. Alejandro F. Frangi WJN, Vincken Koen L., Viergever Max A. Multiscale vessel enhancement filtering. Berlin Heidelberg: Springer 1998.
  23. 23. Wallukat G, Nissen E, Morwinski R, Muller J. Autoantibodies against the beta- and muscarinic receptors in cardiomyopathy. Herz. 2000;25(3):261–6. pmid:10904849
  24. 24. Jahns R, Boivin V, Hein L, Triebel S, Angermann CE, Ertl G, et al. Direct evidence for a beta(1)-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. Journal of Clinical Investigation. 2004;113(10):1419–29. pmid:15146239
  25. 25. Zhang L, Hu D, Shi X, Li J, Zeng W, Xu L, et al. [Autoantibodies against the myocardium beta 1-adrenergic and M2-muscarinic receptors in patients with heart failure]. Zhonghua nei ke za zhi. 2001;40(7):445–7. pmid:11798611
  26. 26. Karczewski P, Hempel P, Kunze R, Bimmler M. Agonistic autoantibodies to the alpha(1) -adrenergic receptor and the beta(2) -adrenergic receptor in Alzheimer’s and vascular dementia. Scandinavian journal of immunology. 2012;75(5):524–30. pmid:22260197
  27. 27. Shin JW, Sung KR, Lee JY, Kwon J, Seong M. Optical coherence tomography angiography vessel density mapping at various retinal layers in healthy and normal tension glaucoma eyes. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2017;255(6):1193–202. pmid:28429123
  28. 28. Park JJ, Soetikno BT, Fawzi AA. Characterization of the middle capillary plexus using optical coherence tomography angiography in healthy and diabetic eyes. Retina (Philadelphia, Pa). 2016;36(11):2039. pmid:27205895
  29. 29. Jia Y, Tan O, Tokayer J, Potsaid B, Wang Y, Liu JJ, et al. Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Optics express. 2012;20(4):4710–25. pmid:22418228
  30. 30. Frangi AF, Niessen WJ, Vincken KL, Viergever MA, editors. Multiscale vessel enhancement filtering1998; Berlin, Heidelberg: Springer Berlin Heidelberg.
  31. 31. Lavia C, Couturier A, Erginay A, Dupas B, Tadayoni R, Gaudric A. Reduced vessel density in the superficial and deep plexuses in diabetic retinopathy is associated with structural changes in corresponding retinal layers. PloS one. 2019;14(7):e0219164. pmid:31318880
  32. 32. Vujosevic S, Toma C, Villani E, Gatti V, Brambilla M, Muraca A, et al. Early Detection of Microvascular Changes in Patients with Diabetes Mellitus without and with Diabetic Retinopathy: Comparison between Different Swept-Source OCT-A Instruments. J Diabetes Res. 2019.
  33. 33. Wang JC, Miller JB. Optical Coherence Tomography Angiography: Review of Current Technical Aspects and Applications in Chorioretinal Disease. Seminars in ophthalmology. 2019;34(4):211–7. pmid:31131663
  34. 34. Jia Y, Bailey ST, Wilson DJ, Tan O, Klein ML, Flaxel CJ, et al. Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration. Ophthalmology. 2014;121(7):1435–44. pmid:24679442
  35. 35. Tian M, Tappeiner C, Zinkernagel MS, Huf W, Wolf S, Munk MR. Evaluation of vascular changes in intermediate uveitis and retinal vasculitis using swept-source wide-field optical coherence tomography angiography. The British journal of ophthalmology. 2018. pmid:30538102
  36. 36. Moghimi S, Hou H, Rao H, Weinreb RN. Optical Coherence Tomography Angiography and Glaucoma: A Brief Review. Asia-Pacific journal of ophthalmology. 2019. pmid:30945480
  37. 37. Werner AC, Shen LQ. A Review of OCT Angiography in Glaucoma. Seminars in ophthalmology. 2019;34(4):279–86. pmid:31158045
  38. 38. Yarmohammadi A, Zangwill LM, Diniz-Filho A, Suh MH, Manalastas PI, Fatehee N, et al. Optical Coherence Tomography Angiography Vessel Density in Healthy, Glaucoma Suspect, and Glaucoma Eyes. Investigative ophthalmology & visual science. 2016;57(9):OCT451–9.
  39. 39. Tepelus TC, Song S, Borrelli E, Nittala MG, Baghdasaryan E, Sadda SR, et al. Quantitative Analysis of Retinal and Choroidal Vascular Parameters in Patients With Low Tension Glaucoma. Journal of glaucoma. 2019;28(6):557–62. pmid:30889061
  40. 40. Hou H, Moghimi S, Zangwill LM, Shoji T, Ghahari E, Manalastas PIC, et al. Inter-eye Asymmetry of Optical Coherence Tomography Angiography Vessel Density in Bilateral Glaucoma, Glaucoma Suspect, and Healthy Eyes. American journal of ophthalmology. 2018;190:69–77. pmid:29580976
  41. 41. Hohberger B HM, Horn F, Kruse FE, Jünemann A. Agonistic β2-AdrenergicReceptor Autoantibodies in Ocular Hypertension and Open-Angle Glaucoma. Invest Ophthalmol Vis Sci 2014;55(13):532.
  42. 42. Nakazawa T, Sato A, Mori A, Saito M, Sakamoto K, Nakahara T, et al. Beta-adrenoceptor-mediated vasodilation of retinal blood vessels is reduced in streptozotocin-induced diabetic rats. Vascular pharmacology. 2008;49(2–3):77–83. pmid:18585480
  43. 43. Mori A, Miwa T, Sakamoto K, Nakahara T, Ishii K. Pharmacological evidence for the presence of functional beta(3)-adrenoceptors in rat retinal blood vessels. Naunyn-Schmiedeberg’s archives of pharmacology. 2010;382(2):119–26. pmid:20503039
  44. 44. Delaey C, Van De Voorde J. Regulatory mechanisms in the retinal and choroidal circulation. Ophthalmic research. 2000;32(6):249–56. pmid:11015035
  45. 45. Mori A, Nakahara T, Sakamoto K, Ishii K. Role of beta3-adrenoceptors in regulation of retinal vascular tone in rats. Naunyn-Schmiedeberg’s archives of pharmacology. 2011;384(6):603–8. pmid:21901314
  46. 46. Frame MD, Dewar AM, Calizo RC, Qifti A, Scarlata SF. Nitrosative stress uncovers potent beta2-adrenergic receptor-linked vasodilation further enhanced by blockade of clathrin endosome formation. American journal of physiology Heart and circulatory physiology. 2018;314(6):H1298–H308. pmid:29569954